Figures
Fig 11, “Mean mucus weight by day in all subjects in the Human Viral Challenge Model.” is a duplicate of Fig 9, “Mean symptom score by day in symptom positive subjects in the Human Challenge Viral Model.” Please view the correct Fig 11 here.
Reference
- 1. Fullen DJ, Noulin N, Catchpole A, Fathi H, Murray EJ, Mann A, et al. (2016) Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE 11(1): e0145902. pmid:26761707
Citation: Fullen DJ, Noulin N, Catchpole A, Fathi H, Murray EJ, Mann A, et al. (2016) Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE 11(6): e0157211. https://doi.org/10.1371/journal.pone.0157211
Published: June 9, 2016
Copyright: © 2016 Fullen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.